Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Philip W. Kantoff, Celestia S. Higano, Neal D. Shore, E. Roy Berger, Eric J. Small, David F. Penson, Charles H. Redfern, Anna C. Ferrari, Robert Dreicer, Robert B. Sims, Yi Xu, Mark W. Frohlich, Paul F. Schellhammer

New England Journal of Medicine, 2010

Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Harvard University, University of Washington, Seattle Cancer Care Alliance, Carolina Urologic Research Center, University of California, San Francisco, Vanderbilt University Medical Center, Sharp HealthCare Foundation, NYU Langone Health, Cleveland Clinic, Dendreon (United States), Eastern Virginia Medical School

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with New England Journal of Medicine. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

5456

Citations

View on Google Scholar

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Abstract

Journal Details

Join JournalsHub

Welcome Back